US 7329502
ZAP-70 expression as a marker for chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)
granted A61PA61P35/02
Quick answer
US patent 7329502 (ZAP-70 expression as a marker for chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Feb 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Department of Health and Human Services
- Grant date
- Tue Feb 12 2008 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 07 2028 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 14
- CPC classes
- A61P, A61P35/02